IRIS
VANNI, IRENE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.917
Totale 2.917
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.917
Totale 2.917
Salva come PNG Salva come JPEG
Città #
Genova 1.965
Rapallo 584
Genoa 357
Bordighera 11
Totale 2.917
Salva come PNG Salva come JPEG
Nome #
Efficacy of motesanib diphosphate in non-small-cell lung cancer. 141
Next Generation Sequencing In Non-Small Cell Lung Cancer: New Avenues Toward The Personalized Medicine. 134
Twenty years of molecular analyses in amyotrophic lateral sclerosis: genetic landscape of Italian patients 127
Uncommon EGFR Exon 19 Mutations Confer Gefitinib Resistance in Advanced Lung Adenocarcinoma 125
Oral vinorelbine in the treatment of non-small-cell lung cancer. 113
Belagenpumatucel-L for the treatment of non-small cell lung cancer 107
Tag-based next generation sequencing: a feasible and reliable assay for EGFR T790M mutation detection in circulating tumor DNA of non small cell lung cancer patients 94
Molecular characterization of hospital-acquired methicillin-resistant Staphylococcus aureus strains in pediatric outbreaks using variable tandem repeat analysis with spa and ClfB typing. 92
Clinical applications of circulating tumor cells in lung cancer patients by cellsearch system 88
Sequential use of vinorelbine followed by gefitinib enhances the antitumor effect in NSCLC cell lines poorly responsive to reversible EGFR tyrosine kinase inhibitors 88
Understanding the checkpoint blockade in lung cancer immunotherapy 86
Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non–small cell lung cancer:18F-FDG PET/CT study 81
Coping with formalin banning in pathology: under vacuum long-term tissue storage with no added formalin 80
Human leukocyte antigen-B (-Bw6/-Bw4 I 80, T 80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis 79
New systemic strategies for overcoming resistance to targeted therapies in non-small cell lung cancer 74
Integrated Somatic and Germline Whole-Exome Sequencing Analysis in Women with Lung Cancer after a Previous Breast Cancer 66
The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients 66
Vinflunine for the treatment of non-small cell lung cancer 63
Current State of Target Treatment in BRAF Mutated Melanoma 63
Exosomes: a new horizon in lung cancer 62
Insights into genetic susceptibility to melanoma by gene panel testing: Potential pathogenic variants in acd, atm, bap1, and pot1 60
An improved method for HLA-B and -C supratyping 58
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 57
Investigational drugs targeting fibroblast growth factor receptor in the treatment of non-small cell lung cancer 56
Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy 56
Whole-genome sequencing as standard practice for the analysis of clonality in outbreaks of meticillin-resistant Staphylococcus aureus in a paediatric setting 55
Activating Killer Immunoglobulin Receptors and HLA-C: A successful combination providing HIV-1 control 51
The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape 50
Afatinib for the treatment of non-small cell lung cancer 46
Prognostic and therapeutic implications of microRNA in malignant pleural mesothelioma 46
Next-generation sequencing workflow for NSCLC critical samples using a targeted sequencing approach by ion torrent PGM™ platform 45
Germline ATM variants predispose to melanoma: a joint analysis across the GenoMEL and MelaNostrum consortia 42
Association Between Response to Nivolumab Treatment and Peripheral Blood Lymphocyte Subsets in Patients With Non-small Cell Lung Cancer 41
Analysis of NADP+-dependent isocitrate dehydrogenase-1/2 gene mutations in pediatric brain tumors: Report of a secondary anaplastic astrocytoma carrying the IDH1 mutation 41
Radiation-Related Deregulation of TUBB3 and BRCA1/2 and Risk of Secondary Lung Cancer in Women With Breast Cancer 40
Development and validation of a multiplex quantitative polymerase chain reaction assay for the detection of Mollicutes impurities in human cells, cultured under good manufacturing practice conditions, and following European Pharmacopoeia requirements and the International Conference on Harmonization guidelines 40
Reply to the Letter to the Editor by C. Nicolazzo et al.: “Circulating cell-free DNA and circulating tumor cells as prognostic and predictive biomarkers in advanced non-small cell lung cancer patients treated with first-line chemotherapy” 37
Detection of ganciclovir resistance mutations by pyrosequencing in HCMV-infected pediatric patients 37
Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments 37
Performance comparison of two commercial human whole-exome capture systems on formalin-fixed paraffin-embedded lung adenocarcinoma samples 36
Spontaneous control of HIV-1 viremia in a subject with protective HLA-B plus HLA-C alleles and HLA-C associated single nucleotide polymorphisms 36
Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications 35
Downregulation of miR-99a/let-7c/miR-125b miRNA cluster predicts clinical outcome in patients with unresected malignant pleural mesothelioma 35
Troubleshooting fine-tuning procedures for qPCR system design 33
A sensible technique to detect mollicutes impurities in human cells cultured in GMP condition 32
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients 30
A NEXT GENERATION SEQUENCING APPROACH TO GENOMIC LANDSCAPE IN MELANOMA PATIENTS: EVOLUTION OF PATIENT-SPECIFIC RESPONSE TO THERAPY 22
Whole exome sequencing of independent lung adenocarcinoma, lung squamous cell carcinoma, and malignant peritoneal mesothelioma: A case report 21
Molecular Assessment in Patients with Melanoma: When and Why? 18
Predictors of germline status for hereditary melanoma: 5 years of multi-gene panel testing within the Italian Melanoma Intergroup 17
Germline POT1 Variants: A Critical Perspective on POT1 Tumor Predisposition Syndrome 2
Totale 3.041
Salva come PNG Salva come JPEG
Categoria #
all - tutte 13.079
article - articoli 12.879
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 94
Totale 26.052
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201988 0 0 0 0 0 0 0 0 0 0 33 55
2019/2020384 23 11 16 26 34 41 58 28 41 55 42 9
2020/2021849 14 11 23 208 32 44 225 61 79 61 57 34
2021/2022554 73 11 17 44 23 34 11 144 17 69 16 95
2022/2023674 56 61 9 59 119 104 2 45 112 8 95 4
2023/2024294 10 47 14 48 24 59 14 41 20 17 0 0
Totale 3.041